Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
eli lilly
genentech
2
×
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
novartis
roche
san francisco blog main
san francisco top stories
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
apalutamide
atypical hemolytic uremic syndrome
avapritinib
bill cassidy
biogen
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
caelum biosciences
cancer drugs
cancer immunotherapy
capmatinib
celgene
chuck grassley
corvus pharmaceuticals
What
drug
latest
2
×
address
alzheimer’s
approval
approves
bio
blueprint
cancer
carries
certain
companies
designed
different
fail
fda
gene
genetic
increases
medicines
pass
pharmaceutical
plan
prescription
price
prices
raise
ret
roundup
signature
signatures
start
targeted
targeting
therapies
therapy
typically
year
Language
unset
Current search:
genentech
×
latest
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
